Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatments on IMA...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anatolian journal of cardiology 2015-08, Vol.15 (8), p.611-617
Hauptverfasser:	Çavuşoğlu, Yüksel, Korkmaz, Şule, Demirtaş, Selda, Gencer, Erkan, Şaşmaz, Hatice, Mutlu, Fezan, Güneş, Hakan, Mert, Uğur Kadir, Özdemir, Sedat, Kalaycı, Süleyman, Yılmaz, Mehmet Birhan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Biomarkers - blood Cardiotonic Agents - administration & dosage Dobutamine - administration & dosage Female Heart Failure - blood Heart Failure - drug therapy Heart Failure - physiopathology Humans Hydrazones - administration & dosage Infusions, Intravenous Male Middle Aged Original Investigation Prospective Studies Pyridazines - administration & dosage Serum Albumin Serum Albumin, Human Treatment Outcome Turkey Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!